Filter
3464
Filtered Results: 3464
Text search:
adverse
health
effects
Featured
Recommendations
361
New Publications
872
Language
Document type
No document type
1910
Studies & Reports
572
Guidelines
559
Manuals
182
Strategic & Response Plan
103
Fact sheets
59
Training Material
44
Situation Updates
16
Infographics
7
Resource Platforms
6
Brochures
3
Videos
2
App
1
Countries / Regions
India
177
Global
138
Kenya
81
South Africa
77
Western and Central Europe
76
Ethiopia
67
Nepal
61
Nigeria
57
Uganda
54
Latin America and the Carribbean
51
Africa
50
Sierra Leone
42
Tanzania
42
Ghana
41
Zambia
40
Malawi
37
Bangladesh
35
Myanmar / Burma
35
Liberia
34
Philippines
32
Rwanda
27
Ukraine
27
Zimbabwe
23
South–East Asia Region
23
Brazil
21
Cambodia
20
Namibia
20
Eastern Europe
20
Syria
19
Indonesia
19
East and Southern Africa
18
Mozambique
15
Asia
15
USA
14
South Sudan
14
Eswatini/ Swaziland
14
Guinea
13
Botswana
13
West and Central Africa
13
Middle East and North Africa
13
Eastern Europe and Central Asia
12
Germany
11
Lesotho
11
Senegal
10
Congo, Democratic Republic of
10
Russia
10
Thailand
9
Sudan
9
Burkina Faso
8
Western Pacific Region
8
Pakistan
7
Colombia
7
Yemen
7
Venezuela
7
Afghanistan
6
Moldova
6
Jordan
5
Lebanon
5
Mali
4
Haiti
4
Somalia
4
China
4
Angola
4
Sri Lanka
4
Chile
4
Paraguay
4
Laos
4
Cameroon
3
Niger
3
Egypt
3
Benin
3
Argentina
3
Ecuador
3
Madagascar
3
Bhutan
3
Timor Leste/ East Timor
3
Tajikistan
3
Vietnam
3
Guinea-Bissau
2
Iraq
2
Gambia
2
Singapore
2
Central African Republic
2
North Macedonia
2
El Salvador
2
Palestine
2
Kyrgyzstan
2
Georgia
2
United Kingdom
2
Belarus
2
Côte d’Ivoire / Ivory Coast
1
Chad
1
Mauritania
1
Ireland
1
Papua New Guinea
1
Vanuatu
1
Peru
1
Burundi
1
Honduras
1
Greece
1
Guatemala
1
Other region
1
Fiji
1
Solomon Islands
1
Poland
1
North Korea
1
Albania
1
Djibouti
1
Canada
1
Romania
1
Lithuania
1
Iran
1
Australia
1
Kazakhstan
1
North America
1
Turkmenistan
1
Spain
1
Authors & Publishers
Publication Years
Category
Countries
1111
Clinical Guidelines
386
Public Health
208
Women & Child Health
200
Key Resources
148
Capacity Building
52
Pharmacy & Technologies
33
Toolboxes
Mental Health
366
COVID-19
289
HIV
224
TB
222
Planetary Health
194
Pharmacy
113
AMR
97
NCDs
97
Caregiver
88
NTDs
86
Rapid Response
84
Conflict
73
Ebola
67
Global Health Education
65
Disability
60
Refugee
57
Natural Hazards
39
Specific Hazards
37
Zika
24
Health Financing Toolbox
18
Cholera
17
Polio
17
Social Ethics
7
Typhoon
2
Updated 10 August 2020
This document presents an essential medicines list (EML) to manage patients in intensive care units (ICUs) with suspected or confirmed COVID-19 diagnosis, which includes active ingredients with dosage form and concentration, and are preferably in the WHO Model Lists of Essent...
This document provides guidance to Member States in the WHO European Region that wish to conduct behavioural insights studies related to COVID-19. Studies can be used to monitor public knowledge, risk perceptions, behaviours and trust with the overall aim to inform national COVID-19 outbreak respons...
These guidelines provide evidence-based guidance on the use of peripartum antiviral prophylaxis in HBsAg-positive pregnant women for the prevention of mother-to-child transmission of HBV.
The primary audience of these recommendations includes healthcare providers who are responsible for developing national and local health protocols (particularly those related to hypertensive disorders of pregnancy), and those directly providing care...
Just about everyone has experienced the joy that a healthy newborn child brings to parents, families and communities. But the arrival of a newborn who is small or sick often results in immediate worry and sadness. When the infant is at high risk of death or disability, these concerns can be a tremen...
It is estimated that more than 311 000 women die of cervical
cancer each year. Of these deaths, 91% occur in low- and
middle-income countries. Demographic changes and a lack of
action mean that the number of deaths per year is projected
to reach 460 000 by 2040.
The recommendation in this document thus supersedes the previous WHO recommendation for the prevention of PPH as published in the 2012 guideline, WHO recommendations for the prevention and treatment of postpartum haemorrhage.
Sepsis contributes significantly to preventable mortality and is the final common pathway to death for severe infectious diseases; it can also arise as a complication of injuries and non-communicable diseases.
General practitioners and pediatricians must know the signs and
symptoms of possible pediatric cancer.
Sepsis remains a leading cause of mortality and morbidity, especially during the first five days of life and in low and middle-income countries (LMIC) [1]. Hospital infection also remains a major cause of mortality in children despite progress encountered in the last decades.
Results of rapid assessment
The COVID-19 pandemic has disrupted or halted critical mental health services in 93% of countries worldwide while the demand for mental health is increasing, according t...
The Global Strategy for Tuberculosis Research and Innovation will support the efforts of governments and other stakeholders to accelerate TB research and innovation, and improve equitable access to the benefits of research.
Availabl in Arabic, Chinese, English, French, Spanish and Russian
The recommendation in this document thus supersedes the previous WHO recommendation for the prevention of PPH as published in the 2012 guideline
The World Health Organization’s comprehensive antenatal care (ANC) guideline WHO recommendations on antenatal care for a positive pregnancy experience was first published in 2016 with the objective of improving the quality of routine ... care that all women and adolescent girls receive during pregnancy. The overarching principle – to provide pregnant service users with a positive pregnancy experience – aims to encourage countries to expand their health-care agendas beyond survival, with a view to maximizing health, human rights and the potential of their populations. Recognizing that ANC provides a strategic platform for important health-care functions, including health promotion and disease prevention, 14 out of the 49 recommendations in the WHO 2016 ANC guideline relate to nutritional interventions in pregnancy.
This twelfth version of the WHO living guideline now contains 19 recommendations. This latest update provides updated recommendations for remdesivir, addresses the use of combination therapy with corticosteroids, interleukin-6 (IL-6) receptor blockers and Janus kinase (JAK) inhibitors in patients wi...
Antimalarial drug resistance has emerged as a threat to global malaria control efforts, particularly in the Greater Mekong subregion. Drawing on data collected through more than 1000 therapeutic efficacy studies as well as molecular marker studies of Plasmodium falciparum drug resistance, the Report...
The World Health Organization organized a Consultation of National Leprosy Programme managers, partners and affected persons to discuss the draft Global Leprosy Strategy, 2021--2030. This virtual event took place from 26 to 30 October 2020. It was a...
WHO technical advisory group on behavioural insights and sciences for health, meeting report, 15 October 2020
